Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2800 of 3284 entries
View as:

Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

Phase: N/A Priority: Normal
NCT ID: NCT03997123 Org: User:
Start: 06/25/19 End: 03/16/26 Due: 03/16/27

INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use

Phase: N/A Priority: Normal
NCT ID: NCT06314282 Org: User:
Start: 10/22/24 End: 11/30/26 Due: 11/30/27

Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin Challenge

Phase: N/A Priority: Normal
NCT ID: NCT01937338 Org: User:
Start: 10/31/13 End: 04/30/14 Due: 04/30/15

Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT04595370 Org: User:
Start: 01/26/21 End: 09/22/23 Due: 09/22/24

A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293

Phase: N/A Priority: Normal
NCT ID: NCT02126514 Org: User:
Start: 05/31/14 End: 05/31/14 Due: 05/31/15

Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network (HEKATE)

Phase: N/A Priority: Normal
NCT ID: NCT03657875 Org: User:
Start: 09/15/17 End: 09/15/17 Due: 09/15/18

Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04612751 Org: User:
Start: 02/02/21 End: 01/30/26 Due: 01/30/27

Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)

Phase: N/A Priority: Normal
NCT ID: NCT00261287 Org: User:
Start: 11/30/05 End: 06/30/06 Due: 06/30/07

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01094093 Org: User:
Start: 04/11/10 End: 07/26/11 Due: 07/26/12

Real World Study With Benralizumab in Severe Asthma in Switzerland

Phase: N/A Priority: Normal
NCT ID: NCT03907137 Org: User:
Start: 01/21/19 End: 01/04/23 Due: 01/04/24

Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00082277 Org: User:
Start: 04/30/04 End: 10/31/07 Due: 10/31/08

Osimertinib Plus Chemotherapy in Uncommon EGFRm NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05215951 Org: User:
Start: 07/06/22 End: 03/09/23 Due: 03/09/24

A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833

Phase: N/A Priority: Normal
NCT ID: NCT05364255 Org: User:
Start: 05/10/22 End: 06/20/22 Due: 06/20/23

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05061550 Org: User:
Start: 04/14/22 End: 05/09/30 Due: 05/09/31

Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00710268 Org: User:
Start: 06/30/08 End: 11/30/09 Due: 11/30/10

This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity/Overweight

Phase: N/A Priority: Normal
NCT ID: NCT07017179 Org: User:
Start: 05/20/25 End: 08/06/26 Due: 08/06/27

Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

Phase: N/A Priority: Normal
NCT ID: NCT06712563 Org: User:
Start: 04/17/25 End: 09/04/26 Due: 09/04/27

Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone

Phase: N/A Priority: Normal
NCT ID: NCT00683657 Org: User:
Start: 07/31/08 End: 02/28/09 Due: 02/28/10

A Study to Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole

Phase: N/A Priority: Normal
NCT ID: NCT05551897 Org: User:
Start: 10/04/22 End: 12/28/22 Due: 12/28/23

Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA

Phase: N/A Priority: Normal
NCT ID: NCT06020014 Org: User:
Start: 11/16/23 End: 12/25/25 Due: 12/25/26

Roflumilast Plus Montelukast in Adults With Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01765192 Org: User:
Start: 02/28/13 End: 10/31/13 Due: 10/31/14

Zomig - Treatment of Acute Migraine Headache in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01211145 Org: User:
Start: 09/30/10 End: 10/31/13 Due: 10/31/14

Management of Diabetes Mellitus Patients With Retinopathy

Phase: N/A Priority: Normal
NCT ID: NCT00828425 Org: User:
Start: 12/31/08 End: 08/31/09 Due: 08/31/10

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00784953 Org: User:
Start: 10/31/08 End: 05/31/11 Due: 05/31/12

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02658214 Org: User:
Start: 04/28/16 End: 11/14/19 Due: 11/14/20